Implication of Fusobacterium necrophorum in recurrence of peritonsillar abscess

S Ahmed Ali1, Kevin J Kovatch1, Josh Smith2

  • 1Department of Otolaryngology Head & Neck Surgery, Ann Arbor, Michigan, U.S.A.

The Laryngoscope
|December 25, 2018
PubMed
Abstract

Insights

Fusobacterium necrophorum (FN) in peritonsillar abscess (PTA) aspirates is linked to higher recurrence rates. Prompt identification and management of FN may reduce PTA reoccurrence.

Area of Science:

  • Otolaryngology
  • Infectious Diseases
  • Microbiology

Background:

  • Peritonsillar abscess (PTA) is a common complication of pharyngeal infections.
  • Streptococcus and Fusobacterium species, particularly Fusobacterium necrophorum (FN), are frequently isolated pathogens.
  • Understanding factors influencing PTA recurrence is crucial for effective patient management.

Purpose of the Study:

  • To investigate the impact of microbial culture results on peritonsillar abscess recurrence after drainage.
  • To identify specific pathogens associated with recurrent PTA.
  • To inform clinical decision-making regarding PTA management and follow-up.

Main Methods:

  • Retrospective review of 156 patients with recurrent PTA and 990 total patients treated between 2000 and 2017.
  • Analysis of demographic data, clinical outcomes, treatment details, and microbiological culture results.
  • Statistical comparison of clinical and microbiological findings between recurrent and non-recurrent PTA cases.

Main Results:

  • 16% of patients experienced PTA recurrence, with higher rates in adolescent and young adult groups.
  • Recurrent PTA patients were more likely to present with acute symptom progression, trismus, voice changes, dysphagia, and lymphadenopathy.
  • Fusobacterium necrophorum (FN) was significantly more prevalent in patients with recurrent PTA (P < 0.0001).

Conclusions:

  • A high prevalence of FN in PTA aspirates is associated with abscess recurrence.
  • Sending PTA aspirates for anaerobic culture to detect Fusobacterium species is recommended.
  • Consider increased surveillance and a lower threshold for tonsillectomy in patients with recurrent PTA, especially those with FN identified.